Generic name: Eperisone hydrochloride
Chemical name: 4-Ethyl-2 methyl-3-piperidinopropiophenone hydrochloride
Spastic paralysis in the following diseases:
Cerebrovascular disease, spastic spinal paralysis, cervical spondylosis, postoperative sequelae (including cerebrospinal tumor), sequelae to trauma (spinal trauma, head injury), amyotrophic lateral sclerosis, cerebral palsy, spinocerebellar degeneration, spinal vascular diseases and other encephalomyelopathies.
Improvement of muscular hypertonic symptoms in the following diseases:
Cervical syndrome, periarthritis of the shoulder, lumbago.
Dosage and Administration
The usual adult dosage for oral use is one tablet three times a day after each meal or as directed by the physician. The dosage should be adjusted depending on the patient age and severity of symptoms.
Usage during Pregnancy, Delivery and Lactation
Safety for use in pregnancy has not been established. Perispa should only be used in pregnant women or women suspected of being pregnant, if therapeutic benefits are evaluated to outweigh the possible risk of treatment.
It is recommended that this drug not be used during lactation. If it must be used at such times, the patients should discontinue breast-feeding during treatment.